当前位置： SCI文献检索 > JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS期刊下所有文献 > Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety.

Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety.

Abstract：

WHAT IS KNOWN AND OBJECTIVE:Based on extrapolation, biosimilar infliximab (IFX) was approved to treat inflammatory bowel disease (IBD). The first studies in adults have shown similar efficacy and safety in comparison with reference drug. The aim of this review was to collect and evaluate all the literature data regarding the use of biosimilar IFX in paediatric IBD. METHODS:This article reviewed efficacy, immunogenicity and safety profile of biosimilar IFX in IBD paediatric patients through a comprehensive search of the published literature. RESULTS AND DISCUSSION:Eight papers were extracted and critically reviewed. Four paediatric studies (prospective, n = 3; retrospective, n = 1) assessed the induction efficacy of the biosimilar IFX. Clinical response and remission rates reported were 86%-90% and 67%-68%, respectively. No significant difference in clinical response and remission rates between the reference and biosimilar IFX groups was found at follow-up (range: 3-13 months). Similar findings were shown in the prospective studies (n = 4) conducted on patients elected to switch from reference IFX to its biosimilar. The most frequently reported adverse events (AEs) of biosimilar IFX were mild upper respiratory tract infections. Taking into account of all AEs coming from published data, biosimilar IFX seems to be as safe as its originator. Immunogenicity has not been significantly impacted by the switch from the reference drug. WHAT IS NEW AND CONCLUSION:To date, treatment with (or switch to) biosimilar IFX in paediatric patients with IBD have been successful, without affecting efficacy, immunogenicity or safety. However, further studies are warranted, including clinical trials and pharmacovigilance studies.

journal_name

J Clin Pharm Ther

journal_title

Journal of clinical pharmacy and therapeutics

authors

Dipasquale V,Romano C

doi

10.1111/jcpt.13239

subject

Has Abstract

pub_date

2020-12-01 00:00:00

pages

1228-1234

issue

6

eissn

0269-4727

issn

1365-2710

journal_volume

45

pub_type

杂志文章,评审

相关文献

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS文献大全
  • Throbbing headache associated with enoxaparin administration: a case report, a review of pharmacovigilance databases for similar cases and possible mechanisms.

    abstract：WHAT IS KNOWN AND OBJECTIVES:To date, no case of headache has been reported with enoxaparin. We present the case of a 60-years-old man, who developed enoxaparin-induced throbbing headache and discuss the possible pharmacological mechanisms. We provide an analysis of enoxaparin-induced headache in three international da...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12257

    authors： Brusadelli T,Carnovale C,Gentili M,Borsadoli C,Speziali A,Perrone V,Pellegrino P,Antoniazzi S,Pozzi M,Radice S,Clementi E

    更新日期：2015-06-01 00:00:00

  • Analysis of clinical characteristics of tigecycline-induced acute pancreatitis.

    abstract：WHAT IS KNOWN AND OBJECTIVE:The purpose of this study is to explore the clinical characteristics of tigecycline-induced acute pancreatitis. METHODS:We searched the PubMed/Medline, Web of Knowledge, OVID, Elsevier, Springer Link, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data, an...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.13212

    authors： Fang W,Yi D,Sun L,Wang C

    更新日期：2020-12-01 00:00:00

  • Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricaemia.

    abstract：WHAT IS KNOWN AND OBJECTIVE:There is much controversy over how angiotensin II receptor blockers (ARB) or angiotensin-converting enzyme inhibitors (ACEI) affect blood uric acid levels. Though ARB is not used to lorcwer the uric acid concentration in the blood, losartan, one of the ARB series, is known to reduce the uric...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.13202

    authors： Kim HS,Kim H,Lee SH,Kim JH

    更新日期：2020-12-01 00:00:00

  • What do we know about the genetics of aspirin intolerance?

    abstract：:Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including aspirin-intolerant asthma (AIA) with rhinitis and aspirin-intolerant urticaria (AIU) with anaphylaxis. Altered eicosanoid metabolism is the generally acce...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,评审

    doi：10.1111/j.1365-2710.2008.00961.x

    authors： Palikhe NS,Kim SH,Park HS

    更新日期：2008-10-01 00:00:00

  • Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Cytochrome P450 1A2 (CYP1A2), CYP2B6 and inducible nitric oxide synthase (iNOS) are involved in the metabolism and action of many important therapeutic drugs, and genetic variants have been associated with interethnic differences in response to treatment, including chemotherapy. METHODS:Eig...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12351

    authors： Qi GZ,Zhang ZY,Wang X,Yin SJ,Lou YQ,Zhang GL

    更新日期：2016-02-01 00:00:00

  • Evaluation of an information booklet for general practitioners with patients on home parenteral nutrition.

    abstract：:An information package was developed for general practitioners (GPs) involved in the management of home parenteral nutrition (HPN) patients. The booklet covered five major sections: background information; HPN training; complications of HPN; arrangements for a particular patient; and hospital management of HPN. This s...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1988.tb00210.x

    authors： Malone M

    更新日期：1988-12-01 00:00:00

  • Colchicine toxicity precipitated by interaction with sunitinib.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Colchicine is an anti-inflammatory agent used primarily in treatment of gout and familial Mediterranean fever. Toxicity is uncommon, and depends on dose, hepatic or renal impairment, co-administration with P-glycoprotein or CYP3A4 inhibitors and route of administration. In patients taking p-...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12047

    authors： Abodunde OA,LevakaVeera RR,Desai R,Nweke N,Berrou M

    更新日期：2013-06-01 00:00:00

  • Comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Patients with type 2 diabetes mellitus (T2DM) are at higher risk of thrombotic complications. Studies have indicated that patients with T2DM have impaired clopidogrel-induced antiplatelet effect. Ticagrelor and prasugrel are two latest generation P2Y12 inhibitors with advantageous platelet i...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1111/jcpt.12651

    authors： Shang LL,Guo DD,Zhao HY,Quan AJ,Cao PG

    更新日期：2018-06-01 00:00:00

  • Heparin-induced thrombocytopenia and recent advances in its therapy.

    abstract：OBJECTIVES:To highlight therapeutic controversies, and present a critical review of the most recent evidence on the management of heparin-induced thrombocytopenia (HIT). DATA SOURCES:A MEDLINE search from October 1996 until October 2006 was carried out. Pertinent literature was identified and other references identifi...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,评审

    doi：10.1111/j.1365-2710.2007.00865.x

    authors： Hassan Y,Awaisu A,Aziz NA,Aziz NH,Ismail O

    更新日期：2007-12-01 00:00:00

  • Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations.

    abstract：:When designing studies of the optimal use of antimicrobial drugs, it is important to define at an early stage, which outcome parameters to use. It must be clear to which category a parameter to be measured belongs: the structure, the process or a clinical outcome. Attention must be paid to the measurement scales as we...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.0269-4727.2003.00518.x

    authors： Natsch S,Kullberg BJ,Hekster YA,van der Meer JW

    更新日期：2003-12-01 00:00:00

  • The impact of a computerized physician order entry system on medical errors with antineoplastic drugs 5 years after its implementation.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Computerized physician order entry (CPOE) systems reduce medical errors (MEs). Nevertheless, a CPOE system may also lead to new types of errors, especially when it is first implemented. The objectives of this study were to determine the impact of a CPOE on the number of MEs and to identify t...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12305

    authors： Sanchez Cuervo M,Rojo Sanchis A,Pueyo Lopez C,Gomez de Salazar Lopez de Silanes E,Gramage Caro T,Bermejo Vicedo T

    更新日期：2015-10-01 00:00:00

  • Plasma transforming growth factor beta1 in breast cancer patients treated with CMF chemotherapy.

    abstract：BACKGROUND:In early breast cancer patients the transformed epithelial cells are thought to be sensitive to transforming growth factor beta1 (TGFbeta1)-mediated growth arrest. TGFbeta1 may therefore act as an anti-tumour promoter. However, in advanced breast cancer resistance to such TGFbeta1 action develops. Neoplastic...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2000.00290.x

    authors： Kajdaniuk D,Marek B,Swietochowska E,Ostrowska Z,Glogowska-Szelag J,Kos-Kudla B,Ciesielska-Kopacz N,Wielkoszyski T

    更新日期：2000-08-01 00:00:00

  • Efficacy and safety of telaprevir and boceprevir in patients with hepatitis C genotype 1: a meta-analysis.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Two NS3/4A protease inhibitors (PIs), telaprevir and boceprevir, were recently approved in the United States. The primary objective was to compare the efficacy and safety of triple therapies including either PI to dual therapy in patients with chronic hepatitis C genotype 1; the secondary ob...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,meta分析,评审

    doi：10.1111/jcpt.12106

    authors： Park C,Jiang S,Lawson KA

    更新日期：2014-02-01 00:00:00

  • Long-acting formulation leading to severe long-term adverse effects: a case report of fluphenazine and persistent extrapyramidal symptoms.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Long-acting formulations are an important therapeutic option for non-adherent patients with schizophrenia. There is a commonly held view that management of long-acting formulation-induced side effects is difficult. CASE DESCRIPTION:We present a patient with schizophrenia who developed acute...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.12589

    authors： Omi T,Mitsui Y,Matsunaga H

    更新日期：2018-02-01 00:00:00

  • Re-elevation of serum amlodipine level after lipid emulsion therapy in an overdose case.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Amlodipine overdose is common; however, the dose and timing of intravenous lipid emulsion (ILE) therapy as a management strategy remain debatable. CASE DESCRIPTION:A 73-year-old man received a single bolus (1.5 mL/kg) of ILE therapy following massive ingestion of multiple drugs, including a...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.13018

    authors： Ando M,Nakasako S,Ariyoshi K,Yamaguchi M,Sakizono K,Minowa K,Fukushima S,Sugioka N,Hashida T

    更新日期：2019-12-01 00:00:00

  • Appropriateness of antiviral prescribing for influenza in primary care: a retrospective analysis.

    abstract：BACKGROUND AND OBJECTIVE:Antiviral medications cost-effectively reduce influenza-related morbidity and potentially mortality. We sought to assess the appropriateness of antiviral prescribing for influenza. METHOD:We performed a retrospective analysis of visits by adults to primary care clinics during influenza seasons...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2006.00731.x

    authors： Linder JA,Chan JC,Bates DW

    更新日期：2006-06-01 00:00:00

  • Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Adverse drug events (ADE), common and underestimated in ICU patients, have direct consequences on length of stay, mortality and hospital costs. Critically ill patients with HIV/AIDS are at a high risk of ADE because of their need for multiple drug therapies. ADE can be prevented, especially ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12222

    authors： Ramos GV,Guaraldo L,Japiassú AM,Bozza FA

    更新日期：2015-02-01 00:00:00

  • Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin.

    abstract：WHAT IS KNOWN:The increased risk of cardiovascular events in diabetic patients has been related to numerous metabolic and haemoreological factors. Some of these factors appear to be particularly evident during the post-prandial phases and to be related to peak plasma glucose level. AIM:To compare the effect of additio...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1111/j.1365-2710.2009.01132.x

    authors： Derosa G,Mereu R,D'Angelo A,Salvadeo SA,Ferrari I,Fogari E,Gravina A,Palumbo I,Maffioli P,Randazzo S,Cicero AF

    更新日期：2010-10-01 00:00:00

  • Drug compliance and the Morisky Adherence Scale: An expression of concern and a warning.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Every prescriber knows that patients often do not take their medicines as prescribed. Hippocrates, the wise man of Kos, knew over two millennia ago. Our objective is to comment on the types of studies aimed at understanding and optimizing drug usage and to draw attention to the need to seek ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 社论

    doi：10.1111/jcpt.13325

    authors： Li-Wan-Po A,Peterson GM

    更新日期：2021-02-01 00:00:00

  • The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Ticagrelor is a reversibly binding and selective P2Y12 -receptor antagonist approved for the prevention of atherothrombotic events in patients with acute coronary syndromes. As bleeding events remain a hazard with antiplatelet therapy, this study investigated the effect of the vasopressin ag...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1111/jcpt.12130

    authors： Teng R,Mitchell PD,Butler K

    更新日期：2014-04-01 00:00:00

  • Survival in end stage renal disease: calcium carbonate vs. sevelamer.

    abstract：BACKGROUND AND OBJECTIVE:There is concern regarding long-term excess calcium intake in end-stage renal disease populations. Because calcium carbonate is an over-the-counter (OTC) medication, few studies have been able to track its use. The Veterans Health Administration (VA) tracks national pharmacy data for both OTC a...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2007.00871.x

    authors： Borzecki AM,Lee A,Wang SW,Brenner L,Kazis LE

    更新日期：2007-12-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of methylprednisolone after one bolus dose compared with two dose fractions.

    abstract：OBJECTIVE:Although the elimination half-life of most glucocorticoids is short, they are usually administered once daily, or even on alternate days. Our hypothesis was that this practice might compromise the immunosuppressive effect of those drugs during the second part of the administration interval. METHODS:Eight hea...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 临床试验,杂志文章

    doi：10.1046/j.1365-2710.2002.00422.x

    authors： Uhl A,Czock D,Boehm BO,Zellner D,Mertz A,Keller F

    更新日期：2002-08-01 00:00:00

  • Pharmacokinetics and safety of bromotetrandrine (BrTet, W198) after single-dose intravenous administration in healthy Chinese volunteers.

    abstract：OBJECTIVE:To investigate the safety and pharmacokinetics of bromotetrandrine (BrTet, W198), a novel inhibitor of P-glycoprotein (P-gp), after single-dose i.v. infusion in healthy Chinese volunteers. METHODS:We conducted a randomized, dose-escalating, phase I clinical study for that purpose. Thirty healthy subjects rec...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1111/j.1365-2710.2009.01075.x

    authors： Zheng L,Qing YP,Xu N,Yu Q,Wang Y,Wang FP,Li ZY

    更新日期：2010-02-01 00:00:00

  • Pharmacokinetics of intravenous midazolam during epidural anaesthesia.

    abstract：:Midazolam concentration curves versus time were analysed in 10 otherwise healthy patients (ASA I-II) with inferior limb pathologies. The benzodiazepine was used as an adjuvant agent to epidural anaesthesia in view of its lower residual effect compared with other intravenous benzodiazepines. Midazolam pharmacokinetics...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1991.tb00306.x

    authors： Sánchez-Alcaraz A,Sangrador G,Laguarda M,Quintana B

    更新日期：1991-06-01 00:00:00

  • Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Mebendazole (MBZ) is a broad-spectrum antihelminthic agent of the benzimidazole type. Although MBZ has been reported to cause hepatic injury, case reports of severe hepatic injury are very rare. We report a case of severe hepatitis after administration of MBZ in a patient with Gilbert's synd...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.13033

    authors： Tolomeo M,Colomba C,Meli M,Cascio A

    更新日期：2019-12-01 00:00:00

  • A systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Rutoside (rutin; quercetin rutinoside) is a glycoside found in various plant products, including apples, citrus fruits and cranberries. Hydroxyethylrutosides (HR) are semisynthetic derivatives sold as standardized products for the treatment of chronic venous insufficiency (CVI). Commercially...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,meta分析,评审

    doi：10.1111/jcpt.12247

    authors： Aziz Z,Tang WL,Chong NJ,Tho LY

    更新日期：2015-04-01 00:00:00

  • Management of acute coronary syndrome in a tertiary care general medical unit in Sri Lanka: how closely do we follow the guidelines?

    abstract：BACKGROUND AND OBJECTIVES:Acute coronary syndrome (ACS) is a leading cause of death. Correct implementation of evidence-based guidelines should improve outcome. We conducted this study to determine to what extent management of ACS in a tertiary care medical ward in Sri Lanka adhered to current guidelines. STUDY METHOD...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2009.01115.x

    authors： Rajapakse S,Rodrigo PC,Selvachandran J

    更新日期：2010-08-01 00:00:00

  • Baking soda misuse as a home remedy: case experience of the California Poison Control System.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Baking soda is a common household product promoted by the manufacturer as an antacid. It contains sodium bicarbonate and has the potential for significant toxicity when ingested in excessive amounts. Characterizing the patterns and outcomes from the misuse of baking soda as a home remedy can...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12113

    authors： Al-Abri SA,Kearney T

    更新日期：2014-02-01 00:00:00

  • Treatment of acute otitis media in patients with a reported penicillin allergy.

    abstract：:Otitis media occurs commonly in children, and is usually treated with an antibiotic. In this case report, amoxicillin was prescribed for a 6-year-old boy suffering from acute otitis media. As he had previously experienced a rash after the administration of a penicillin, the medication order was switched from amoxicill...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2000.00268.x

    authors： Falconer CL,Gardner DM

    更新日期：2000-06-01 00:00:00

  • Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Massive acute arsenic poisoning is rare yet potentially life-threatening. 2,3-dimercaptopropane-1-sulphonate (DMPS) appears to have the appropriate chelating property. However, clinical experience on the use of DMPS in massive arsenic poisoning is limited. CASE DESCRIPTION:A 37-year-old wom...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.12538

    authors： Lu PH,Tseng JC,Chen CK,Chen CH

    更新日期：2017-08-01 00:00:00